Microgestin 1.5/30 NDC 51862-872

NDC codes

FDA NDC Directory

Product NDC (as listed)51862-872Labeler and product segments. Claims need a package NDC.

Product NDC at billing width51862-0872Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
51862-872-01	51862087201	1 BLISTER PACK in 1 PACKET (51862-872-01) / 1 KIT in 1 BLISTER PACKMarketed from Oct 11, 2020
51862-872-02	51862087202	1 BLISTER PACK in 1 CARTON (51862-872-02) / 1 KIT in 1 BLISTER PACKMarketed from Oct 11, 2020
51862-872-03	51862087203	3 BLISTER PACK in 1 CARTON (51862-872-03) / 1 KIT in 1 BLISTER PACKMarketed from Oct 11, 2020

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Microgestin 1.5/30
Generic name (nonproprietary): norethindrone acetate/ethinyl estradiol
Dosage form: Kit
Labeler: Mayne Pharma Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 202996
Marketing start: Oct 11, 2020
Listing expires: Dec 31, 2026
Identifiers: Product ID 51862-872_b951b698-58e3-4a2a-a039-2589f6acf308SPL ID b951b698-58e3-4a2a-a039-2589f6acf308SPL set ID 9f49a476-596c-46e1-b67b-d3d40de84216RxCUI 1359022, 1359028, 1359032

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

NDC on a medical claim

N451862087201 followed by a unit qualifier and the quantity

Package 51862-0872-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 9, 2025. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE Microgestin 1.5/30 is indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception. Oral contraceptives are highly effective. Table 1 lists the typical accidental pregnancy rates for users of combination oral contraceptives and other methods of contraception. The efficacy of these contraceptive methods, except sterilization, depends upon the reliability with which they are used. Correct and consistent use of methods can result in lower failure rates. 2

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 202996

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 202996
Product	Strength	Form · route	Labeler	Product NDC
Microgestin 1.5/30norethindrone acetate/ethinyl estradiol	—	Kit	Dr. Reddys Laboratories Inc.	75907-083
Larin 1.5/30norethindrone acetate/ethinyl estradiol	—	Kit	Northstar Rx LLC	16714-407

Microgestin 1.5/30 (norethindrone acetate/ethinyl estradiol) NDC 51862-872